ARCHIVES

Gemcitabine Improves DFS In Resected Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000